Dr. Waskin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
90 E. Scott Avenue
Building 34
Rahway, NJ 07065- Is this information wrong?
Summary
- MD with Board certified internal medicine/infectious diseases with professional interest in public health epidemiology, fungal diseases, HIV, and immunocompromised host. Expertise in pharmaceutical research as clinical team leader.
Education & Training
- Centers for Disease Control and PreventionFellowship, Infectious Disease, 1985 - 1987
- University of New Mexico School of MedicineFellowship, Infectious Disease, 1984 - 1985
- Rush University Medical CenterResidency, Internal Medicine, 1978 - 1981
- University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
- NJ State Medical License 2001 - 2025
- NC State Medical License 1988 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia.Gregory Winchell, Rik de Greef, Aziz Ouerdani, Floris Fauchet, Rebecca E Wrishko, Eric Mangin, Christopher Bruno, Hetty Waskin> ;Antimicrobial Agents and Chemotherapy. 2024 Apr 3
- 1 citationsPharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.Johan A Maertens, Galia Rahav, Dong-Gun Lee, Shariq Haider, Isabel Cristina Ramirez-Sanchez, Nikolai Klimko, Alfredo Ponce-de-León, Seongah Han, Rebecca Wrishko, Grego...> ;Clinical Drug Investigation. 2023 Sep 1
- 4 citationsDouble-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).Thomas J Sferra, Tomas Merta, Michael Neely, Claudia Murta de Oliveira, Alvaro Lassaletta, Claudia Fortuny Guasch, Mary Beth Dorr, Gregory Winchell, Feng-Hsiu Su, Sara...> ;Journal of the Pediatric Infectious Diseases Society. 2023 Jun 30
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: